Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Carcinoma, Transitional Cell × trastuzumab deruxtecan × 90 days × Clear all

Sponsor

Conditions

Breast Neoplasms 23 Neoplasm Metastasis 10 Stomach Neoplasms 6 Colorectal Neoplasms 5 Carcinoma, Non-Small-Cell Lung 5 Brain Neoplasms 5 Ovarian Neoplasms 4 Endometrial Neoplasms 4 Salivary Gland Neoplasms 3 Pancreatic Neoplasms 3 Neoplasms 3 Adenocarcinoma 3 Triple Negative Breast Neoplasms 2 Recurrence 2 Prostatic Neoplasms 2 Esophageal Neoplasms 2 Vulvar Neoplasms 1 Vaginal Neoplasms 1 Uterine Neoplasms 1 Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 Urethral Neoplasms 1 Thyroid Neoplasms 1 Testicular Neoplasms 1 Solid Cancer 1 Small Cell Lung Carcinoma 1 Sarcoma 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Osteosarcoma 1 Mouth Neoplasms 1

Interventions

pembrolizumab 22 enfortumab vedotin 14 Magnetic Resonance Spectroscopy 10 Specimen Handling 9 Nivolumab 9 Gemcitabine 9 avelumab 8 Cisplatin 8 atezolizumab 7 Carboplatin 7 sacituzumab govitecan 5 Docetaxel 5 Ipilimumab 4 durvalumab 3 Paclitaxel 3 lenvatinib 2 erdafitinib 2 dodecyl maltoside 2 cabozantinib 2 Taxes 2 Mitomycin 2 Immunoglobulin G 2 Fluorodeoxyglucose F18 2 CTLA-4 Antigen 2 Biopsy 2 ALT-803 2 zimberelimab 1 zanidatamab 1 toripalimab 1 tocilizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡